The Ayers Institute at Vanderbilt University Medical Center

About the Program


The Ayers Institute for Precancer Detection and Diagnosis was established on July 1, 2005 at Vanderbilt University Medical Center.

The objectives of the Ayers Institute are as follows:

  • To detect cancers and precancers at their earliest stages
  • To develop diagnostic tests to assess the prognosis for cancers and to predict responses to cancer treatment
  • To advance the science and technology of cancer detection and diagnosis

Led by Daniel Liebler, Ph.D., the Ayers Institute applies new proteomics technologies to identify protein biomarkers for cancer. Vanderbilt University Medical Center is recognized worldwide for leadership in proteomics technologies.

The Ayers Institute brings together a research team spanning basic and clinical research disciplines to advance the science behind new diagnostics, to save lives and to prevent suffering due to cancer.

For further information, please visit The Ayers Institute at Vanderbilt-Ingram Cancer Center